Trastuzumab for the treatment of primary breast cancer in HER2-positive women: a single technology appraisal
Ward S, Pilgrim H, Hind D
Record ID 32013000712
English
Details
Project Status:
Completed
Year Published:
2009
URL for published report:
http://www.journalslibrary.nihr.ac.uk/hta/hta13Suppl1-01/#/abstract
URL for additional information:
http://www.journalslibrary.nihr.ac.uk/hta/volume-13/suppl-1-article-1
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Antibodies, Monoclonal, Humanized
- Clinical Trials, Phase III as Topic
- Cost-Benefit Analysis
- Technology Assessment, Biomedical
- Trastuzumab
- Antibodies, Monoclonal
- Antineoplastic Agents
- Breast Neoplasms
- Receptor, ErbB-2
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
Copyright:
2009 Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.